Synercid Drug Information [ Sanofi-Aventis; Healthcare Logistics, New Zealand; King Pharmaceuticals; Monarch Pharmaceuticals; Nordic Pharma ]

Table of content

Synercid category:

• Human

Active ingredients:

• Dalfopristin Mesylate
• Quinupristin Mesylate

Synercid companies and manufacturers:

• Sanofi-Aventis

• Healthcare Logistics, New Zealand

• King Pharmaceuticals

• Monarch Pharmaceuticals

• Nordic Pharma

General Information

Synercid forms, composition and dosages:

• Injectable; IV (Infusion); Dalfopristin Mesylate 350 mg; Quinupristin Mesylate 150 mg
• Injectable; IV (Infusion); Dalfopristin Mesylate 420 mg; Quinupristin Mesylate 180 mg

Indications, usages and classification codes:

• J01FG02 - Quinopristin and Dalfopristin

• Synercid analogs